Article Details

Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based ...

Retrieved on: 2022-06-25 16:11:19

Tags for this article:

Click the tags to see associated articles and topics

Intellia and Regeneron Present Updated Interim Data from Phase 1 Study of CRISPR-based .... View article details on hiswai:

Excerpt

Intellia Therapeutics, a leading clinical-stage genome editing company, ... PipelineReview.com is powered by La Merie Business Intelligence La ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up